MooreSRadyPTyringS. Acquired epidermodysplasia verruciformis: clinical presentation and treatment update. Int J Dermatol. 2022;61(11):1325-1335. doi:10.1111/ijd.15857
3.
BlauveltAKempersSLainE, et al. Phase 3 trials of tirbanibulin ointment for actinic keratosis. N Engl J Med. 2021;384(6):512-520. doi:10.1056/NEJMoa2024040
4.
MillerACAdjeiSTemizLATyringSK. Tirbanibulin for the treatment of actinic keratosis: a review. Skin Therapy Lett. 2022;27(4):4-7.
5.
GilaberteYFernández-FiguerasMT. Tirbanibulin: review of its novel mechanism of action and how it fits into the treatment of actinic keratosis. Actas Dermosifiliogr. 2022;113(1):58-66. doi:10.1016/j.ad.2021.07.006
6.
MooreAYMooreS. Topical tirbanibulin eradication of periungual squamous cell carcinoma. JAAD Case Rep. 2021;14:101-103. doi:10.1016/j.jdcr.2021.06.013
7.
BraaschSGerberPABraunSA. Tirbanibulin 1% ointment as a potential novel treatment for anogenital warts. J Eur Acad Dermatol Venereol. 2022;36(6):e468-e470. doi:10.1111/jdv.17957
